The Indegene IPO has surpassed all expectations, with remarkable subscription figures and an unprecedented Grey Market Premium (GMP) of ₹290. Dive into the details of this historic offering and its implications for investors.
Table of Contents
Unprecedented Subscription Figures
The Indegene IPO witnessed an overwhelming response from investors, with subscription figures reaching new heights:
- Qualified Institutional Buyers (QIB): Oversubscribed by a staggering 192 times.
- High Net Worth Individuals (HNI): Subscribed at a remarkable 54.6 times.
- Retail Investors: Demonstrated strong interest with a subscription rate of 7.7 times.
Total Subscription: 70x
Tentative Allotment Matrix
The tentative allotment matrix provides insights into the allocation process:
- B-HNI: 4 out of 49 applicants will receive 462 shares each.
- S-HNI: 2 out of 81 applicants will be allotted 462 shares each.
- Retail Investors: 4 out of 23 applicants will receive 33 shares each.
The Grey Market Premium (GMP) for the Indegene IPO has surged to an all-time high of ₹290, reflecting investor confidence and market optimism.
Conclusion
The Indegene IPO has set new benchmarks in the primary market, with unprecedented subscription figures and a record-breaking Grey Market Premium. As investors eagerly await the listing date, the success of this offering serves as a testament to the confidence and enthusiasm of market participants.